Gene: CACNB2
Official Full Name: calcium voltage-gated channel auxiliary subunit beta 2provided by HGNC
Gene Summary: This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10905 | CACNB2 Knockout cell line (HeLa) | Human | CACNB2 | 1:3~1:6 | Negative | Online Inquiry |
KO10906 | CACNB2 Knockout cell line (HCT 116) | Human | CACNB2 | 1:2~1:4 | Negative | Online Inquiry |
KO10907 | CACNB2 Knockout cell line (HEK293) | Human | CACNB2 | 1:3~1:6 | Negative | Online Inquiry |
KO10908 | CACNB2 Knockout cell line (A549) | Human | CACNB2 | 1:3~1:4 | Negative | Online Inquiry |
CACNB2 Gene Knockout Cell Lines are expertly developed cellular models that facilitate the study of the CACNB2 gene, which encodes the beta subunit of voltage-gated calcium channels. These cell lines have been genetically engineered to exhibit a complete knockout of the CACNB2 gene, allowing researchers to investigate the physiological and pathological roles of calcium signaling in a controlled environment. By eliminating this gene, scientists can observe the associated changes in cellular behaviors, calcium influx, and various downstream signaling pathways.
The primary mechanism through which the CACNB2 knockout impacts cellular function revolves around the modulation of calcium ion permeability. Without the beta subunit, voltage-gated calcium channels may exhibit altered gating dynamics, leading to disruptions in calcium-dependent processes such as neurotransmitter release, muscle contraction, and gene expression regulation. Thus, this product is indispensable for elucidating the contributions of CACNB2 to both normal physiology and disease states, such as neurodegenerative disorders, cardiac conditions, and other calcium-related pathologies.
In research and clinical settings, these knockout cell lines serve as powerful tools for drug screening, mechanism-based studies, and the exploration of calcium signaling pathways. Their unique ability to model diseases linked to aberrant calcium channel activity allows for the development of targeted therapies, making them of high value in both academic and pharmaceutical research.
Compared to other models, the CACNB2 Gene Knockout Cell Lines stand out due to their precise genetic modifications and the resultant clarity in experimental outcomes. They offer consistency and reproducibility, crucial for reliable data generation. Additionally, the ease of use and versatility for various experimental applications enhance their desirability among researchers and clinicians alike.
By investing in CACNB2 Gene Knockout Cell Lines, users gain access to a cutting-edge resource that enhances their capacity to unravel the complexities of calcium signaling and its implications in health and disease. Our company's extensive expertise in developing high-quality biological products ensures that you are equipped with the most reliable tools to advance your research initiatives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.